DNMT1 and posterior cortical atrophy: Beyond a deeper understanding of PCa pathogenesis, the validation of our pioneer findings could lead to the development of a novel class of PCa therapeutic agents that selectively target sarcosine N‐demethylating enzymes to decrease their impact on the SAMe‐Dnmt epigenetic axis.